| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | US20040138193 Administering by mouth |
| 07/15/2004 | US20040138190 Steroidal quinols and their use for estrogen replacement therapy |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138095 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | CA2512188A1 Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
| 07/14/2004 | EP1437140A1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 07/14/2004 | EP1437138A1 Use of 7-oxo DHEA in the modulation of the metabolism of a dieting mammal |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436395A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436281A1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/14/2004 | EP1436257A1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 07/14/2004 | EP1436254A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/14/2004 | EP1435929A1 Composition comprising cysteamine for improving lactation in dairy animals |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512886A Use of antiprogestins for prophylaxis and treatment or hormone-dependent diseases |
| 07/14/2004 | CN1512883A Crf受体拮抗剂 Crf receptor antagonist |
| 07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 07/14/2004 | CN1157379C Tetrahydroquinoline derivatives |
| 07/14/2004 | CN1157192C Pharmaceutical application of crust holoside and derivant thereof |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | CA2453282A1 Method of modulating the basal metabolic rate of a dieting mammal by administration of a metabolic modulating agent to the dieting mammal |
| 07/08/2004 | WO2004056780A2 Tetrahydroquinoline derivatives |
| 07/08/2004 | WO2004056779A2 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 07/08/2004 | WO2004056378A1 Means for preventing and curing endocrine system disturbances |
| 07/08/2004 | WO2004056368A1 Therapeutic applications of 2-substituted 4-heteroarylryrimidines |
| 07/08/2004 | WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2003002058A9 Bone anabolic compounds and methods of use |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040133031 Crystal of bicalutamide and production method thereof |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132770 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132650 Human growth hormone for treating children with abnormal short stature and kits and methods for diagnosing gs protein dysfunctions |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | CA2510459A1 Means for preventing and curing endocrine system disturbances |
| 07/08/2004 | CA2502138A1 Therapeutic applications of 2-substituted 4-heteroarylryrimidines |
| 07/07/2004 | EP1435240A2 Solid oral dosage form comprising a combination of methformin and glibenclamide |
| 07/07/2004 | EP1434885A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 07/07/2004 | EP1434797A2 Insulin mimetic amino acid sequences |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434786A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434586A1 Estrogen/gestagen combination preparation and application thereof |
| 07/07/2004 | EP1434583A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/07/2004 | EP1434575A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 07/07/2004 | EP1401431A4 Human growth hormone antagonists |
| 07/07/2004 | EP1278523B1 Combination of progesterone and mifepristone for cancer therapy |
| 07/07/2004 | EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 07/07/2004 | EP1006794A4 A method for treating or preventing alzheimer's disease |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511041A Methods of treating antibody-mediated pathologies using agents which inhibit CD 21 |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1509718A Medicine releasing composition for improving steroid compound stability |
| 07/07/2004 | CN1156492C Somatostatin peptides |
| 07/06/2004 | US6759547 Reduces serum glucose and serum triglyceride levels in diabetic mammals without the undesirable properties of reducing serum thyroxine levels and transiently raising triglyceride levels |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/01/2004 | WO2004055009A1 Novel compounds having selective inhibiting efect at gsk3 |
| 07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004055005A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004054977A1 Nicotinamide-based kinase inhibitors |
| 07/01/2004 | WO2004054609A1 Placental alkaline phosphatase to control diabetes |
| 07/01/2004 | WO2004054567A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 07/01/2004 | WO2004054566A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
| 07/01/2004 | WO2004054565A1 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 07/01/2004 | WO2004054558A2 Reduction of breast density with 4-hydroxy tamoxifen |
| 07/01/2004 | WO2004054555A1 Novel dry powder inhalation system for transpulmonary administration |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | WO2003003986A3 Parathyroid hormone antibodies and related methods |
| 07/01/2004 | US20040127576 Estrogen receptor modulators |
| 07/01/2004 | US20040127555 bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; treatment of A beta , IAPP, other amyloids, and alpha -synuclein or NAC fibrillogenesis |
| 07/01/2004 | US20040127503 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126420 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 07/01/2004 | CA2508297A1 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 07/01/2004 | CA2508045A1 Novel compounds having selective inhibiting efect at gsk3 |
| 07/01/2004 | CA2505788A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
| 06/30/2004 | EP1433478A1 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |